Literature DB >> 6683381

Olfactory impairment in Parkinson's disease.

C D Ward, W A Hess, D B Calne.   

Abstract

In comparison with closely matched controls, patients with Parkinson's disease had reduced scores in tests of odor detection and qualitative discrimination. Olfactory impairment was not related to age, duration of symptoms, treatment, intellectual function, or genetic factors and seemed to be a nonmotor manifestation of the disease.

Entities:  

Mesh:

Year:  1983        PMID: 6683381     DOI: 10.1212/wnl.33.7.943

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease.

Authors:  N Sobel; M E Thomason; I Stappen; C M Tanner; J W Tetrud; J M Bower; E V Sullivan; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

3.  Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.

Authors:  Y H Kim; S Lussier; A Rane; S W Choi; J K Andersen
Journal:  Neuroscience       Date:  2010-11-03       Impact factor: 3.590

4.  Olfactory threshold in Parkinson's disease.

Authors:  N P Quinn; M N Rossor; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

5.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein.

Authors:  Wai Haung Yu; Yasuji Matsuoka; István Sziráki; Audrey Hashim; John Lafrancois; Henry Sershen; Karen E Duff
Journal:  Neurochem Res       Date:  2007-11-13       Impact factor: 3.996

7.  Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity.

Authors:  Hilary Afeseh Ngwa; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2013-12-18       Impact factor: 4.294

8.  Evaluation of olfactory function by topographic EEG analysis in patients with Parkinson's disease.

Authors:  S Gori; R Massetani; L Murri
Journal:  Ital J Neurol Sci       Date:  1995-12

9.  Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.

Authors:  Sheila M Fleming; Nicole A Tetreault; Caitlin K Mulligan; Ché B Hutson; Eliezer Masliah; Marie-Françoise Chesselet
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

10.  Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI.

Authors:  Thomas Jubault; Simona M Brambati; Clotilde Degroot; Benoît Kullmann; Antonio P Strafella; Anne-Louise Lafontaine; Sylvain Chouinard; Oury Monchi
Journal:  PLoS One       Date:  2009-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.